ALX Oncology
ALXO
#9346
Rank
NZ$0.25 B
Marketcap
NZ$1.94
Share price
3.92%
Change (1 day)
-23.91%
Change (1 year)

EPS for ALX Oncology (ALXO)

EPS in 2026 (TTM): NZ-$1.96

According to ALX Oncology's latest financial reports the company's current EPS (TTM) is NZ-$2.07. In 2025 the company made an earnings per share (EPS) of NZ-$3.47 an increase over its 2024 EPS that were of NZ-$4.75.

EPS history for ALX Oncology from 2020 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$1.96-43.65%
2025NZ-$3.47-26.92%
2024NZ-$4.75
2022NZ-$5.5447.09%
2021NZ-$3.7739.49%
2020NZ-$2.70

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ-$2.47 19.47%๐Ÿ‡บ๐Ÿ‡ธ USA